Table 2.
Treatment-related toxicities for treated patients (n = 70)
| Toxicity type | Grade |
|
|---|---|---|
| 3 (n) | 4 (n) | |
| Hematologic | ||
| Hemoglobin | 1 | 0 |
| Leukocytes | 22 | 6 |
| Febrile neutropenia | 2 | 0 |
| Lymphopenia | 3 | 1 |
| Neutrophils | 17 | 14 |
| Generalized | ||
| Allergic reaction | 2 | 1 |
| Fatigue | 6 | 0 |
| Weight loss | 7 | 0 |
| Burn | 0 | 1 |
| Rash/desquamation/acneiform | 11 | 0 |
| Radiation dermatitis/burn | 15 | 1 |
| Neuropathy | 1 | 0 |
| Thrombosis | 1 | 0 |
| Dehydration | 7 | 0 |
| Head and neck/GI | ||
| Anorexia | 12 | 1 |
| Diarrhea | 3 | 0 |
| Dry mouth | 4 | 0 |
| Dysphagia | 20 | 0 |
| Esophagitis | 1 | 0 |
| Muco/stomatitis (symptom) oropharynx | 34 | 2 |
| Nausea | 2 | 0 |
| Vomiting | 2 | 0 |
| Oral cavity pain | 4 | 0 |
| Throat/pharynx/larynx pain | 2 | 0 |
| Tumor pain | 1 | 0 |
| Pulmonary airway | ||
| Bronchospasm, wheezing | 0 | 1 |
| Dyspnea | 2 | 0 |
| Obstruction—airway larynx | 0 | 1 |
| Voice changes/dysarthria | 3 | 0 |
| Infection with Gr 0–2 neutrophils | ||
| Bladder | 1 | 0 |
| Colon | 2 | 0 |
| Urinary tract/catheter | 3 | 0 |
| Oropharynx mucosa | 6 | 0 |
| Foreign body/skin | 3 | 0 |
| Anal canal | 1 | 0 |
| Electrolyte—abnormalities | 0 | |
| Potassium | 3 | 0 |
| Sodium | 1 | 0 |
| Phosphorus | 3 | 0 |
| Magnesia | 2 | 1 |
| Glucose | 1 | 0 |
| Bilirubin | 1 | 1 |
| Calcium | 0 | 1 |
| Creatinine | 1 | 0 |
| Worst degree | 43 | 21 |